“AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability”, EMSGH, vol. 3, pp. 38–47, Oct. 2026, doi: 10.70267/emsgh.v3.3847.